American Association for Cancer Research (AACR) shared on LinkedIn:
“We are saddened by the loss of V. Craig Jordan, a former AACR Board member and Fellow of the AACR Academy who passed away June 9 at the age of 76.
A pioneer of hormone therapy for the treatment of breast cancer, Dr. Jordan changed the lives of generations of women faced with a breast cancer diagnosis through his groundbreaking research on tamoxifen.
We offer heartfelt condolences to his family, friends, and colleagues.”
Additional information.
Source: AACR/LinkedIn